GUILLAIN–BARRÉ SYNDROME: COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, DIAGNOSIS, AND MANAGEMENT

Fuente: Zenodo
Guardado en:
Detalles Bibliográficos
Autor principal: RAJENDIRAN, KAMESH
Formato: Recurso digital
Lenguaje:Idioma anglosajón
Publicado: Zenodo 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866901867688099840
author RAJENDIRAN, KAMESH
author_facet RAJENDIRAN, KAMESH
contents <p>Guillain–Barré Syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy characterized by rapidly progressive, symmetrical weakness of the limbs with areflexia. It is the most common cause of acute flaccid paralysis worldwide after the eradication of poliomyelitis. The disease involves an aberrant immune response leading to demyelination or axonal damage of peripheral nerves, often following infections like Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, or influenza virus. Diagnosis relies on clinical features, cerebrospinal fluid (CSF) analysis showing albuminocytologic dissociation, and nerve conduction studies. Management focuses on immunotherapy (IVIg or plasma exchange) and supportive care. Early diagnosis and treatment significantly improve outcomes.</p> <p>Guillain–Barré Syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy characterized by rapidly progressive, symmetrical weakness of the limbs with areflexia. It is the most common cause of acute flaccid paralysis worldwide after the eradication of poliomyelitis. The disease involves an aberrant immune response leading to demyelination or axonal damage of peripheral nerves, often following infections like Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, or influenza virus. Diagnosis relies on clinical features, cerebrospinal fluid (CSF) analysis showing albuminocytologic dissociation, and nerve conduction studies. Management focuses on immunotherapy (IVIg or plasma exchange) and supportive care. Early diagnosis and treatment significantly improve outcomes.</p> <p> </p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_17496657
institution Zenodo
language ang
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle GUILLAIN–BARRÉ SYNDROME: COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, DIAGNOSIS, AND MANAGEMENT
RAJENDIRAN, KAMESH
Neurosurgery
<p>Guillain–Barré Syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy characterized by rapidly progressive, symmetrical weakness of the limbs with areflexia. It is the most common cause of acute flaccid paralysis worldwide after the eradication of poliomyelitis. The disease involves an aberrant immune response leading to demyelination or axonal damage of peripheral nerves, often following infections like Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, or influenza virus. Diagnosis relies on clinical features, cerebrospinal fluid (CSF) analysis showing albuminocytologic dissociation, and nerve conduction studies. Management focuses on immunotherapy (IVIg or plasma exchange) and supportive care. Early diagnosis and treatment significantly improve outcomes.</p> <p>Guillain–Barré Syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy characterized by rapidly progressive, symmetrical weakness of the limbs with areflexia. It is the most common cause of acute flaccid paralysis worldwide after the eradication of poliomyelitis. The disease involves an aberrant immune response leading to demyelination or axonal damage of peripheral nerves, often following infections like Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, or influenza virus. Diagnosis relies on clinical features, cerebrospinal fluid (CSF) analysis showing albuminocytologic dissociation, and nerve conduction studies. Management focuses on immunotherapy (IVIg or plasma exchange) and supportive care. Early diagnosis and treatment significantly improve outcomes.</p> <p> </p>
title GUILLAIN–BARRÉ SYNDROME: COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, DIAGNOSIS, AND MANAGEMENT
topic Neurosurgery
url https://doi.org/10.5281/zenodo.17496657